|
Market Closed -
Nasdaq
16:00:00 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 7.210 USD | -2.44% |
|
-1.10% | -26.13% |
| 09-14 | Alumis Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-14-2026 07:45 AM | |
| 09-10 | Top Premarket Gainers | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 933M | - | ||||
| 74.41B | |||||
| 59.26B | |||||
| 47.14B | |||||
| 42.91B | |||||
| 44.13B | - | - | - | - | - |
- Stock Market
- Stocks
- ALMS Stock
- Charts Alumis Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
